PROCTOLOG

This brand name is authorized in Spain, Romania, Singapore, Turkey

Active ingredients

The drug PROCTOLOG contains a combination of these active pharmaceutical ingredients (APIs):

1 Ruscogenin UNII BXI92R2VUJ - RUSCOGENIN

Read about Ruscogenin

2 Trimebutine UNII QZ1OJ92E5R - TRIMEBUTINE

Trimebutine maleate is a noncompetitive spasmolytic agent. It possesses moderate opiate receptor affinity and has a marked antiserotonin activity especially on ‘M’ receptors. It induces regulation of spontaneous activity and increases synchronization between electrophysiological spikes and contractions in isolated guinea pig taenia coli and ileum. However, it does not alter normal motility, but regulates abnormal intestinal activity. Read about Trimebutine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C05AX03	Other preparations, combinations	C Cardiovascular system → C05 Vasoprotectives → C05A Agents for treatment of hemorrhoids and anal fissures for topical use → C05AX Other agents for treatment of hemorrhoids and anal fissures for topical use
Discover more medicines within C05AX03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 54647, 54648
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65042001
Country: SG	Health Sciences Authority	Identifier(s): 03023P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8681308331007, 8681308891006